CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,447,879 | -35.2% | 1,822,530 | -1.1% | 0.00% | -100.0% |
| Q2 2023 | $19,207,956 | +39.7% | 1,843,374 | -6.6% | 0.00% | – |
| Q1 2023 | $13,751,371 | +88.2% | 1,972,937 | +62.8% | 0.00% | – |
| Q4 2022 | $7,307,836 | -4.8% | 1,211,913 | +24.4% | 0.00% | – |
| Q3 2022 | $7,678,000 | -46.3% | 974,383 | -7.2% | 0.00% | – |
| Q2 2022 | $14,297,000 | -61.9% | 1,050,508 | -45.2% | 0.00% | -100.0% |
| Q1 2022 | $37,564,000 | -39.3% | 1,915,548 | +6.2% | 0.00% | -50.0% |
| Q4 2021 | $61,894,000 | +1.9% | 1,803,958 | +62.3% | 0.00% | 0.0% |
| Q3 2021 | $60,711,000 | -21.8% | 1,111,495 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $77,658,000 | +705881.8% | 1,056,861 | +910987.1% | 0.00% | – |
| Q1 2021 | $11,000 | -81.7% | 116 | -84.4% | 0.00% | – |
| Q4 2020 | $60,000 | -97.5% | 744 | -98.6% | 0.00% | – |
| Q3 2020 | $2,443,000 | – | 52,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |